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Abstract: Acidic microenvironments in solid tumors is a hallmark of 
cancer. Inspired by that, we designed a family of pseudopeptidic 
cage-like anionophores displaying pH-dependent activity. When 
protonated, they efficiently bind chloride anion as shown by NMR 
titration in aqueous acetonitrile. They also transport chloride through 
lipid bilayers (ISE experiments in POPC liposomes), being the 
anionophoric properties improved at acidic pH, which suggests an 
H+/Cl- symport mechanism. NMR studies in DPC micelles 
demonstrate the ability of the cages to bind chloride within the lipid 
phase. Moreover, the corresponding affinity and the chloride 
exchange rate with the aqueous bulk solution are improved when the 
pH is lowered. These results offer insights into the process at the 
molecular level. This behavior induces an increased cytotoxicity 
towards lung adenocarcinoma cells in the pH conditions mimicking 
those of the solid tumors. Besides, all these properties are finely tuned 
by the nature of the side chains of the cages, namely the external 
decoration of the molecules that modulates their lipophilicity and 
potential interactions with the cell membrane. Our study paves the 
way towards using pH as a parameter to control the selectivity of 
cytotoxic ionophores as anti-cancer drugs. 
The accurate control of local pH, with specific values in the 
different cellular compartments and organelles, is essential for the 
correct function of living cells.[1] Specifically, tumor tissues are 
characterized by a reverse pH gradient compared to normal 
tissues, with a slightly basic intracellular pH (pHi) and an acidic 
extracellular pH (pHe), as a result of the altered cancer cell 
metabolism.[2] This pH pattern allows cancer cells to escape from 
apoptosis,[3] as well as to promote cell migration and metastasis.[4] 
Accordingly, the design of drugs able to specifically work in the 
acidic microenvironment around the solid tumors has been 
suggested as a putative mechanism to improve selectivity in 
cancer chemotherapy.[5] Small molecule ionophores have been 
recently proposed as cancer therapeutics, since their ability to 
transport ions through cell membrane can upset cellular 
homeostasis, alter membrane polarization state and impact 
intracellular pH levels, eliciting cytotoxic effects.[6] Despite very 
potent anionophores with biological activity have been reported,[7] 
the selectivity toward tumors or cancer cells is an important but 
still unaddressed issue.[8] Thus, we envisioned the possibility to 
design small peptide-like receptors for chloride that could show 
pH-modulated affinity and transmembrane transport abilities,[9] 
with the aim to display an enhanced cytotoxicity in acidic 
environments. To that, we decided to exploit the structure of 
pseudopeptidic tripodal cages that had shown a very selective 
chloride binding when protonated,[10,11] and good abilities to 
transport this anion through artificial lipid bilayers.[11] In order to 
tune the physicochemical properties and the potential interactions 
with the cell membrane, we considered different aromatic side 
chains deriving from naturally occurring Phe, Tyr and Trp, as well 
as the non-natural O-Me-Tyr and 4-F-Phe (compounds 1a-e in 
Figure 1). 
 
Figure 1. Chemical structure of the pseudopeptidic cages 1a-e and solid state 
structure of the 1b·4HCl salt (X-ray diffraction) with the encapsulated chloride 
in CPK. Additional chloride counterions, solvent molecules and non-polar 
hydrogen atoms have been omitted for clarity. 
The pseudopeptidic cages were prepared following a 
modification of the previously reported methodology,[11] and 
experimental details are provided in the Electronic Supporting 
Information (ESI). All the cages were accurately characterized by 
spectroscopic techniques and, for two of them, the corresponding 
crystal structures of the tetra-HCl salts were resolved by X-ray 
diffraction. In these two examples (see 1b in Figure 1 and 1d in 
Figure S39 at the ESI) one of the chloride counterions is tightly 
bound inside the cavity of the cage through strong H-bonding 
interactions, as we have previously observed for related 
hosts.[10,11] These solid-state structures supported the ability of the 
protonated systems to efficiently encapsulate a chloride anion. 
We also studied the binding properties of the cages by NMR 
titration of their protonated forms with TBACl in aqueous 
acetonitrile (Table 1). 
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Table 1. Chloride affinity (logK1:1, logK1:2, BC50°), hydrophobicity (calculated logP, HPLC retention time), chloride efflux rates in model liposomes (%Cl·s-1, at different 
pHi / pHe) and MTT cytotoxicity in A549 cell lines (IC50 in µM at different external pH) for the cages 1a-e. 





BC50° (µM)[b] logP[c] tR (min)[d] 
7.2 / 7.2 6.2 / 7.2 6.2 / 6.2 pHe 7.5 pHe 7.1 pHe 6.2 
1a 4.01(8) 2.2(2) 96±17 3.90 8.017 0.092 0.091 0.159 60±4 60±3 55±5 
1b 3.7(1) 2.2 198±44 3.63 8.431 0.039 0.055 0.078 145±35 118±16 95±25 
1c 3.82(3) 2.2(1) 148±10 4.31 9.435 0.121 0.151 0.198 166±35 58±10 29±4 
1d n.d.[e] n.d.[e] n.d.[e] 2.81 5.067 0.059 0.1[f] 0.16[f] >200 >200 >200 
1e 3.40(3) 2.1(1) 380±24 4.04 8.148 0.14[f] 0.05[f] 0.128[f] >200 >200 ~170 
[a] By NMR titration, standard deviation on the last significant figure in parenthesis. [b] As defined in ref. [12]. [c] Calculated using VCCLab software with the cages 
as free amines. [d] Retention time in HPLC C18 reverse phase (see ESI for details). [e] Partial precipitation precluded the accurate fitting of the titration data. [f] The 
numerical values must be considered with caution since the ISE traces showed an initial efflux that was not maintained during the experiment time (see Figures 
S58-60 in the ESI). 
 
Interestingly, we observed their ability to bind two chloride anions 
with very different binding constants for the corresponding 1:1 
(104 M-1) and 1:2 complexes (102 M-1). This result is consistent 
with the encapsulation of an anion along with a weaker interaction 
with a second chloride. Likewise, similar chloride affinities 
(BC50°)[12] were found, reflecting a conserved binding pocket for 
all the receptors. 
The ionophoric activity of compounds 1a-e was first explored 
in model phospholipid bilayers by using POPC liposomes (Figure 
2).[13,14] First, the ability of these compounds to facilitate chloride 
efflux from chloride-loaded vesicles was monitored using a 
chloride selective electrode (ISE).[13a] The liposome suspension 
was placed in an isotonic, chloride-free medium and the studied 
cages were added as aliquots of stock solutions. Percent chloride 
efflux for each compound was monitored over time, since release 
of all encapsulated chloride by addition of a detergent allowed the 
normalization of the chloride leakage. Unspecific detergent 
effects induced by these compounds were ruled out with control 
experiments in vesicles loaded with carboxyfluorescein[13d] 
(Figure S62 in the ESI). Different internal and external pH 
conditions were tested (Figure 2A and Table 1). The conditions 
for these experiments were chosen to be comparable to those 
expected under physiological conditions in terms of pH values and 
gradients. The cages showed moderate chloride transport 
abilities, being the efficiency dependent on the nature of the side 
chains. Thus, in general, the most efficient transporter was 1c, 
derived from 4-F-Phe, that is the most hydrophobic of the series. 
The specific behavior in the presence of a pH gradient is also very 
noticeable (Figure 2 and Table1). The use of acidic pHi and 
neutral pHe produced an increase of the chloride transport 
promoted by 1c (X = F), which was much lower with 1b (X = OMe) 
and negligible for 1a (X = H, compare orange and blue traces in 
Figure 2A). The use of both acidic pHi and pHe increased the 
chloride transport rates of the three cages, though to a different 
extent (red traces in Figure 2A). Thus, the fastest rate and highest 
effect of the acid medium was observed with the fluorinated cage 
1c. This result was also confirmed by monitoring chloride influx 
using lucigenin fluorescent dye[13c] (Figure S61 in the ESI). 
Additional experiments with vesicles loaded with a ratiometric 
fluorescent probe sensitive to pH (HPTS)[14] proved that these 
compounds efficiently dissipate pH gradients (Figure 2B). The 
relative efficiency was found well correlated to the relative activity 
as chloride transporters measured using ISE and lucigenin 
assays. Overall, the results suggest a H+/Cl- symport mechanism 
for the 1a-c cages that is facilitated by acidic media and strongly 
dependent on the nature of the host side chain. 
 
Figure 2. (A) ISE experiments to measure the chloride efflux promoted by 1a-c 
cages at different internal and external pH. Each plot shows the average of three 
experiments. (B) HPTS assay showing the ability of 1a-c to dissipate pH 
gradients through lipid bilayers (10% cage to POPC molar ratio, ESI for details). 





In order to obtain a more precise picture of the process at the 
molecular level, we carried out NMR studies of 1c in an aqueous-
lipid phase.[15] To that, deuterated-DPC micelles were suspended 
in D2O and a solution of 1c in DMSO-d6 was added. Different 
conditions of the external aqueous phase were studied ranging 
from neutral to acidic pH, and also in the absence and presence 
of salt (Figure 3). The DOSY NMR experiments performed in all 
the samples showed self-diffusion rates compatible with the total 
incorporation of the cage within the micelles (Table S8 in the ESI). 
Thus, 1c showed an apparent hydrodynamic radius (rH) of 2.9 nm, 
in a very good agreement with the reported size of DPC 
micelles,[16] and much larger than the rH of the cage when DOSY 
experiments were performed with 1c in DMSO-d6 (0.66 nm alone 
and 0.76 nm with protonated 1c and TBACl). The observed 
changes of the NMR spectra of 1c within the micelles upon 
variations in the composition of the external aqueous solution 
were also very illustrative. The proton NMR of the sample at pH 
7.1 showed the presence of two set of signals for some of the 
protons, which were especially important for those of the aromatic 
side chains (Figure 3). Since there is always a low concentration 
of chloride in these samples (~2-3 mM for pH adjustment), we 
assigned these signals to the free and chloride-bound cage 
complexes in slow exchange in the chemical shift NMR timescale. 
The addition of external NaCl induced minor changes (line 
broadening) in the NMR spectra, as expected by the weak 
chloride binding of the non-protonated cage. Interestingly, when 
the pH of the bulk aqueous solution was lowered, the addition of 
NaCl produced a dramatic increase of the signals for the chloride-
bound cage, demonstrating the ability of 1c to strongly bind HCl 
within the lipid phase. 
 
Figure 3. NMR experiments (500 MHz, 303 K) performed with 1c (0.4 mM) in 
deuterated DPC micelles (25 mM, ~one molecule of 1c per DPC micelle) 
suspended in D2O at different pH values and upon addition of 150 mM NaCl. 
The aromatic region showed signals for the free (○) and the chloride-bound (●) 
cage at slow exchange in the chemical shift NMR timescale. 
Fortunately, the observation of split signals for the free and bound 
species allowed us to estimate the chloride exchange rate by 
EXSY experiments.[17] The sample in acid medium showed a 
much faster chloride exchange (kex = 2.7 s-1 at 303 K) than the 
one at neutral pH (kex = 0.2 s-1 at 303 K). The difference in the 
exchange rate was observed in several signals of the cages 
(Figures S77-S79 and S82 in the ESI). Accordingly, we concluded 
that the external aqueous acid medium produced a much stronger 
chloride binding and a much faster chloride exchange with a cage 
that remains in the lipid phase. To the best of our knowledge, this 
is the first direct experimental measurement of this type of 
processes occurring in an aqueous-lipid interface. Moreover, the 
fact that the aromatic signals of 1c were strongly affected by the 
process also suggested the active participation of the fluorinated 
side chain, most likely through CH-anion or anion-π transient 
interactions.[18] 
The biological activity of the cages in living cells was tested in 
a human lung adenocarcinoma cell line (A549) as a proof of 
concept. Thus, the cytotoxicity of all the studied cages was 
determined using the MTT assay[19] (Figure 4 and Table 1). In 
order to test our hypothesis, we performed the experiments at 
different pHe values, namely using the standard conditions 
(DMEM medium, pHe 7.5) and with the presence of PIPES buffer 
to fix a slightly more acidic external medium (pHe 7.2 and 6.2).[5b] 
Compounds 1a-c displayed cytotoxic activities with interesting pH 
dependence, whereas 1d,e were found essentially nontoxic. The 
Phe derivative rendered IC50 values unaffected by pHe, while the 
O-Me-Tyr counterpart showed a slightly higher activity as the pHe 
was lower. The performance of 1c bearing the 4-F-Phe derivative 
was especially interesting, since this receptor systematically 
increased the cytotoxicity as the pHe was decreased (Figure 4 and 
Table 1). Most remarkably, 1c showed to be five-fold more 
cytotoxic at acidic pHe than under the conventional conditions. 
This allows a relatively wide concentration window (50-150 M) 
for which 1c would be safe for cells surrounded by weakly basic 
pH (healthy cells conditions), but cytotoxic for cells in an acidic 
microenvironment (such as for solid tumors). The trends observed 
for the biological activity at different pHe values correlated well 
with the trends observed for the transport assays in model 
liposomes. Moreover, the MTT assays with 1c at reduced 
concentration of chloride also showed a decreased cytotoxicity 
(Figure S83 in the ESI). Overall, these results are in good 
agreement with a key role of the ionophoric activity of compounds 
1a-c in the observed biological activity. 
 
Figure 4. Schematic representation of the cytotoxicity experiments (A549 cell 
line) and plots of the percent cell viability versus the concentration of the cages 
1a-c, performed at different pHe values (referenced to their corresponding 
blanks, see ESI). The results correspond to the average of two independent 
experiments performed in triplicates each (error bars show standard deviation). 
In conclusion, we have developed small pseudopeptidic 
cages able to exchange HCl through aqueous-lipid interfaces. 
The specific behavior of these transporters depend on the nature 
of the amino acid side chains. Thus, a fluorinated Phe derivative 
showed an increased HCl transport ability and a higher 
cytotoxicity to cancer cells in the presence of pH gradients 





resembling those characteristic of tumor microenvironments. Our 
results open the way to further design new pH-dependent 
anionophores for applications in cancer chemotherapy, with the 
aim to improve their selectivity for the target. 
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Material and Methods 
 
General 
Reagents and solvents were purchased from commercial suppliers (Adrich, Fluka or Merck) and were used without further purification. 
Compound 1a was synthetized as previously described1. All the compounds prepared were fully characterized by the complete 
spectroscopic (NMR, ESI-MS) and analytical data. Preparative reverse phase purifications were performed on an Isolera Biotage 
instrument (KP-C18-HS, CH3CN and water with 0.1% TFA). Analytical RP-HPLC was performed with a Hewlett Packard Series 1100 
(UV detector 1315A) modular system using a reverse-phase Kromasil 100 C8 (15 x 0.46 cm, 5 µm) column. CH3CN-H2O mixtures 
containing 0.1% TFA at 1 mL/min were used as mobile phase and monitoring wavelengths were set at 220, 254 and 280 nm. 
 
NMR spectroscopy 
The NMR experiments were carried out at 25˚C on a VNMRS-400 NMR spectrometer (Agilent Technologies 400 MHz for 1H and 100 
MHz for 13C) for characterization and a Bruker Avance-III 500 MHz spectrometer equipped with a z-axis pulsed field gradient triple 
resonance (1H, 13C, 15N) TCI cryoprobe (500 MHz for 1H and 125 MHz for 13C). Chemical shifts are reported in ppm using tetrakis-
trimethylsilylsilane as a reference. Data were processed with the software program MNova (Mestrelab Research). 
 
ESI mass spectrometry 
High resolution mass spectra (HRMS) were performed on Acquity UPLC System and a LCT PremierTM XE Benchtop orthogonal 
acceleration time-of-flight (oa-TOF) (Waters Corporation, Milford, MA) equipped with an electrospray ionization source. All sample 
solution (in the 1 x 10-4 to 1 x 10-6 M range) were prepared in methanol. 
 
NMR spectroscopy in micelles. 
All data were acquired using a Bruker Avance-III 500 MHz spectrometer equipped with a z-axis pulsed field gradient triple resonance 
(1H, 13C, 15N) TCI cryoprobe. For all NMR experiments with cages in presence of DPC-d38 (dodecylphosphocholine) micelles, we 
worked at 25 mM monomer concentration, well above cmc (1.36 mM in PBS).2 For the incorporation of pseudopeptidic cages into DPC 
micelles, a homogeneous solution of detergent in D2O was prepared and the cage was added from a weighted stock solution prepared 
in DMSO-d6. After vigorous vortexing to assure the incorporation of the cage to the micelles (also checked by diffusion coefficient 
measurements, see below), the pH was adjusted. Due to the limited solubility of pseudopeptidic host in aqueous solution, the samples 
in DPC/D2O solution have a final concentration of 0.4 mM cage  with a ~1:1 cage:DPC micelles ratio (using known aggregation number 
~ 55-60).3 The samples at these concentrations were stable and optically clear (without observable precipitation or phase separation) 
over all the NMR experiments. Regarding the pH adjustment, preliminary studies showed that using a buffer (in D2O) could interfere 
with anion recognition.4 In our case, even using Tris·HCl in low concentration (20 mM, cited at the literature as one of the buffers with 
the least competitive chloride counteranion), interfered with chloride binding and caused sample precipitation. Thus, all the cage/DPC 
samples were prepared in D2O without any buffer and the pH (acidic or neutral) was adjusted using the minimum amount of DCl/NaOD 
(from a 0.2 M stock in D2O), so at the end of the pH adjustment the added chloride concentration was always lower than 6-7 mM. 
 
Two-dimensional (2D) spectra (NOESY, ROESY, COSY and HSQC) were acquired at 303 K. For samples in DPC-d38/D2O, the water 
resonance was suppressed by ‘‘3-9-19’’ pulse sequence with gradients using flip-back pulse in NOESY experiments (pulse sequence 
noesyfpgpphwg), 3-9-19 suppression sequence in ROESY experiments (pulse sequence roesygpph19) and presaturation for COSY 
experiments (pulse sequence cosygpprqf). 1H-1H NOESY spectra were acquired with a mixing time of 150 ms (in DPC) and 250 ms (in 
DMSO-d6) and 1H-1H ROESY spectra with a mixing time between 2-75 ms. The comparison of NOESY and ROESY spectra allowed 
to detect those cross peaks in NOESY spectra originated by spin-diffusion and to identify exchange peaks. 2D 1H-13C HSQC 
experiments were acquired with Bruker pulse sequence hsqcdietgpsisp. 2D experiments were processed with the standard TOPSPIN 
program (Bruker Biospin, Karlsruhe, Germany). The 2D data matrices were multiplied by square-sine bell window function with the 
corresponding shift optimized for every spectrum and zero-filled to 2x1 K complex matrices prior to Fourier transformation. Baseline 
correction was applied in both dimensions.  
Exchange constants were calculated using the software EXSYCALC 1.0 (MestreLab Research). In brief, for the calculation of rate 
exchange constants, the program requires the experimental intensities of NMR peaks obtained from two EXSY experiments: one at a 
certain mixing time large enough for the magnetization exchange to take place (tm), and another acquired at a mixing time short enough 
not to see exchange peaks (reference). In the first experiment the volume integrals of those signals in exchange, A(tm), are quantified 
for both diagonal and cross peaks. In the EXSY reference experiment, since no exchange peaks are observed, the amplitudes of just 
the diagonal peaks, A(0), are measured. The values of these integrals are introduced in EXSYCALC 1.0 and the program directly 
computes the corresponding exchange rate constants, by solving the full relaxation matrix of the system.5 
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For PFG-NMR diffusion experiments, the field gradient strength (Gz) was calibrated by measuring the self-diffusion coefficient of 
residual H2O in a 100 % 2H2O sample at 298.0 K. A diffusion coefficient of 1.91 × 10−9 m2 s−1 for the residual H2O signal was then used 
for the back calculation of the field gradient strength.6 For D2O samples, diffusion NMR experiments were acquired at 303 K using 
Shigemi tubes to minimize convection effects.7 The stebpgp1s19 pulse sequence with WATERGATE 3-91-9 for water suppression and 
one spoil gradient was used. The diffusion coefficient, D, was determined by fitting diffusion weighted intensities of selected peaks or 
integrals over a chosen range to the following equation:  
 
I=I0exp{−γ2g2δ2(Δ−δ/3) D} (Eq. 1) 
 
Where γ is the gyromagnetic ratio of proton and g, δ and Δ are the amplitude, duration and separation of the single pair of gradient 
pulses, respectively. Due to the use of bipolar gradient elements, Δ is replaced by (Δ − τ1/2) in Eq. (1), with τ1 being the time interval 
between the bipolar gradient pulses within the bipolar gradient encoding or decoding segment. Fittings to Eq. (1) were performed using 
Bruker Dynamics Center.   
The pulsed-field-gradient signal attenuation was monoexponential for all resonances. In the case of DPC, this indicated that the 
exchange of lipid molecules between micelles and free solution is fast in the NMR time scale. Under these conditions, the observed 
diffusion coefficient is the weighted average of the free (Dfree) and micellar (Dmic) values: 
 
Dobs = ffreeDfree + fmicDmic (Eq. 2) 
 
In which ffree and fmic are the mole fraction of free and micellar DPC. The measured self-diffusion coefficients values obtained for the 
pseudopeptidic cage in different media conditions (DMSO-d6, micelles/D2O at different pH and with/without 150 mM NaCl) and 
dodecylphosphocholine protons (residual non-deuterated protons) are shown in Table S1. The self-coefficient diffusion for DPC protons 
((CH2)n and CH3) are in the range 10-12x10-11 m2/s (at 303K in D2O), similar to known values from DPC micelles in literature,8,9 a 
confirmation that in our experimental conditions we have micellar aggregates. The reason for DPC self-diffusion coefficients being 
higher than the values from absorbed cage is the presence of free monomeric DPC molecules (with concentration smaller than cmc) 
in fast exchange with micelles in solution. However, the observed cage resonances and their self-diffusion coefficients, smaller than 
DPC diffusion coefficients, mainly correspond to DPC-bound molecules and act as a probe for the cage incorporation to the micelles, 
so Dmic (DPC) ~ Dcage (micelle-bound cages).  
 
Fluorescence 
Fluorescence emission was recorded using a HITACHI F-7000 Fluorescence spectrophotometer equipped with stirrer. Two different 
types of cuvettes were used depending on the assay: standard 10 mm quartz glass cells from Hellma Analytics High Precision Cell 
made of Quartz SUPRASIL or disposables MAPM-F10-100 labbox cuvettes. All measurements were performed at 25 °C unless 
specified. 
 
Chloride Selective Electrode measurements 
Chloride concentration in transport experiments was recorded using a Combination Chloride Electrode HI4107 Hanna Instruments and 
a Chloride Selective Electrode 96 52 C Crison.  
 
pH measurements were made using a CRISON pHmeter 50 14 T. 
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Results and Discussion 
Synthetic methodology 
 
Synthesis of 1b 
 




Figure S1. Structure of 2b.   
Boc-Tyr(Me)-OH (375 mg, 1.27 mmol) was dissolved in dry DMF (2.5 mL). N-(3 Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC·HCl O.394 mg, 1.53 mmol), 1-Hydroxybenzotriazole hydrate (HOBt, 0.207 mg, 1.53 mmol), N,N-
Diisopropylethylamine (DIPEA, 0.8 mL, 4.6 mmol) and tris(2-aminoethyl)amine (0.06 mL, 0.38 mmol) were added over the solution. 
The solution was stirred at room temperature for 16 hours, when no more conversion of the starting material was observed by TLC. 
The mixture was diluted with water and extracted with DCM (3 X 10 mL). Combined organic fractions were washed with aqueous LiCl 
(5% w/w), dried over MgSO4 and concentrated to dryness. The residue was purified by flash chromatography using DCM:MeOH 95:5 
to give 0.298 mg of 2b (0.307 mmol, 80% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.69 (s, 3H), 7.15 (A subsystem from AB, JAB=8.3 Hz, 6H), 6.76 (B subsystem from AB, JAB=8.4 
Hz, 6H), 5.65 (d, J=8.8 Hz, 3H), 4.67 (X subsystem from ABX, JAX=6.3, JBX=8.6 Hz, 3H) 3.77 (s, 9H), 3.35 (m, 3H), 3.01 (A subsystem 
from ABX, JAB=13.8, JAX=6.3 Hz, 3H), 2.86 (dd, B subsystem from ABX, JAB=13.8, JBX=8.6 Hz, 3H) 2.84 (m, 3H), 2.48 (m, 3H), 2.39 (m, 
3H), 1.32 (s, 27H). 





13C NMR (101 MHz, CDCl3): δ(ppm)=189.3, 181.1, 172.9, 158.2, 158.2, 130.3, 113.6, 55.6, 55.1, 54.9, 38.7, 38.3, 28.3.  (Data obtained 
from HSQC and HMBC spectra) 
 










Figure S2. 1H-NMR (400 MHz, CD3OD), HSQC and HMBC spectra of 2b 
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3b (2S,2'S,2''S)-N,N',N''-(nitrilotris(ethane-2,1-diyl))tris(2-amino-3-(4 methoxyphenyl) propanamide) 
 
Figure S4. Structure of 3b.  
2b (153 mg, 0.156 mmol) was dissolved in DCM (1.5 ml). Triethylsilane (0.35 mL, 2.34 mmol) and trifluoroacetic acid (1 mL) were then 
added. The solution was stirred at room temperature during 3 hours and then solvents were evaporated under an air current affording 
a yellow oil. The residue was washed several times with diethyl ether and dried affording 3b·4TFA as a white solid (166 mg, 0.145 
mmol, 93% yield). The resulting solid was dissolved in NaOH 1M and extracted with ethyl acetate to eliminate the TFA and obtain the 
free amine.  
 
1H NMR (400 MHz, CD3OD): δ(ppm)=7.18 (d, J=8.7 Hz, 6H), 6.91 (d, J=8.7 Hz, 6H), 4.03 (X subsystem from ABX, JAB=7.3, JBX=7.4 
Hz, 3H), 3.79 (s, 9H), 3.29 (m, 6H), 3.12 (B subsystem from ABX, JAB=14.1, JBX=7.4 Hz, 3H), 3.00(A subsystem from ABX, JAB=14.1, 
JAX=7.3 Hz, 3H), 2.65 (m, 6H). 
 
13C NMR (101 MHz, CD3OD): δ(ppm)= 197.9, 187.4, 158.7, 154.1, 142.5, 83.4, 82.9, 81.3, 64.7, 63.5 . 
 
HRMS (ESI-TOF) m/z [3b + H]+ Calc.: 678.3974, found:  678.4558 
 
   




Figure S5. 1H-NMR (400 MHz, CD3OD) spectra of 3b·4TFA. and 13C-NMR (101 MHz, CD3Cl) spectra of 3b. 
 


























Figure S7. Structure of 1b.  
3b (143.2 mg, 0.126 mmol) was dissolved in dry acetonitrile (50 mL). Bu4Cl (34 mg, 0.076 mmol) and K2CO3 (349 mg, 3 mmol) were 
added to the solution. 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (50 mg, 0.126 mmol) was dissolved in acetonitrile (10 mL) and 
the solution was added to the reaction containing 3b. Reaction mixture refluxed for 16 hours. Solvent was evaporated and the resulting 
crude was purified by flash chromatography The residue was purified by flash chromatography using DCM:MeOH 95:5 as eluent to 
give 1b (43 mg, 50 mmol, 40% yield).  
  
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.23 (d, J=8.6 Hz, 6H, H12), 7.18 (m, 3H, NH), 6.89 (d, J=8.6 Hz, 6H, H11), 3.81 (s, 9H, H14), 
3.73 (ABq, δA=3.77 , δB=3.69, JAB=13.6 Hz, 6H, H5), 3.42 (X subsystem from ABX, JAX=7.5, JBX=4.6 Hz, 3H, H4), 3.22 (B subsystem 
from ABX, JAB=4.0, JBX=4.6 Hz, 3H, H9),  2.97 (m, 6H, H2 and A subsystem from ABX H9 overlapped), 2.65 (m, 6H, H1 H2), 2.34 (m, 
3H, H1), 2.29 (s, 9H, H14). 
 
13C NMR (100 MHz, CDCl3): δ(ppm)=174.2 (C3), 158.5 (C7), 135.1 (C6), 130.7 (C12), 130.5 (C10),129.6 (C13), 114.3 (C11), 63.5 (C4), 
57.6 (C1), 55.3 (C14), 46.3 (C5), 41.0 (C2), 37.1 (C9), 15.3 (C8). (Data obtained from HSQC and HMBC spectra) 
 
HRMS (ESI-TOF) m/z [1b + H]+ Calc.: 834.4913, found:  834.5082 
 
  







Figure S8. 1H-NMR (400 MHz, CD3OD), HSQC and HMBC spectra of 1b. 
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Synthesis of 1c  
 




Figure S10. Structure of 2c.  
Boc-Phe(4-F)-OH (299 mg, 1.057 mmol) was dissolved in dry DMF (2.5 mL). N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC·HCl O.254 mg, 1.28 mmol) and 1-Hydroxybenzotriazole hydrate (HOBt, 0.196 mg, 1.28 mmol), N,N-
diisopropylethylamine (DIPEA, 0.67 mL, 3.84 mmol) and tris(2-aminoethyl)amine (0.05 mL, 0.32 mmol) were added over the solution. 
The solution was stirred at room temperature for 16 hours, when no more conversion of the starting material was observed by TLC. 
The mixture was diluted with water and extracted with DCM (3 X 10 mL). Combined organic fractions were washed with aqueous LiCl 
(5% w/w), dried over MgSO4 and concentrated to dryness. The residue was purified by flash chromatography using 95:5 DCM:MeOH 
to give 0.254 mg of 2c (0.239 mmol, 85% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.72 (s, 3H), 7.20 (dd, J=8.5, 5.5 Hz, 6H), 6.90 (t, J=8.7 Hz, 2H), 5.71 (d, J=9.0 Hz, 3H), 4.70 (X 
subsystem from ABX JAX=13.7, JBX=8.8 Hz, 3H), 3.35 (m, 3H), 3.02 (A subsystem from ABX, JAX=13.7, JAB=6.4 Hz, 3H), 2.87 (B 
subsystem from ABX JBX=8.8 Hz JAB=6.4 Hz, 3H), 2.79 (m, 3H), 2.43 (m, 6H), 1.32 (s, 27H). 
 
13C NMR (101 MHz, CD3Cl):  δ(ppm)=173.0, 156.4, 131.1, 131.0, 115.2, 115.0, 80.1, 55.8, 55.1, 39.0, 38.7, 28.4. 
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Figure S11. 1H-NMR (400 MHz, CD3Cl) and 13C-NMR (101 MHz, CD3Cl) spectra of 2c 
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3c (2S,2'S,2''S)-N,N',N''-(nitrilotris(ethane-2,1-diyl))tris(2-amino-3-(4-fluorophenyl)propan amide) 
 
Figure S13. Structure of 3c.  
2c (173 mg, 0.183 mmol) was dissolved in DCM (1mL) and triethylsilane (TES, 0.414 mL, 2.756 mmol) and TFA (1mL) were added. 
The solution was stirred at room temperature for 3 hours. The solvents were then evaporated under an air current affording a yellow 
oil. The residue was washed several times with diethyl ether and dried affording 3c·4TFA as a white solid (166 mg, 0.145 mmol, 93% 
yield).  
 
1H NMR (400 MHz, CD3OD): δ(ppm)=7.33 (dd, J=8.5, 5.2 Hz, 6H), 7.09 (t, J=8.7 Hz, 6H), 4.13 (X subsystem from ABX, JAX=7.2, 
JBX=7,6 Hz, 3H), 3.33 (m, 6H), 3.16 (A subsystem from ABX , JAX=7.2, JAB=14 Hz, 3H), 3.07 (B subsystem from ABX, JBX=7.6, JAB=14 
Hz, 3H) 2.59 (m, 6H). 
 
13C NMR (101 MHz, CD3OD): δ(ppm)=168.5, 131.0, 130.1, 115.5, 115.3, 54.3, 52.6, 36.4. 
 








Figure S14. 1H-NMR (400 MHz, methanol-d3) and 13C-NMR (101 MHz, methanol-d3) spectra of 3c 
 
Figure S15. HRMS (ESI+) experimental spectrum of 3c.  
Lucia/Supram
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Figure S16. Structure of 1c.  
3c (173 mg, 0.158 mmol) was dissolved in ACN (40 mL). Tetrabuthylamonium chloride (22 mg, 0.079 mmol), 1,3,5-tris(bromomethyl)-
2,4,6-trimethylbenzene (62 mg,  0.158mmol) and potassium carbonate (435 mg, 3.15 mmol) were added over the solution. The reaction 
mixture was refluxed for 16 hours. After cooling down, the solution was filtered, solvent was evaporated and the resulting crude was 
purified by flash column chromatography DCM:MeOH 95:5 as eluent to give 1c (47mg, 59 mmol, 40% yield).  
 
1H NMR (400 MHz, CD3OD): δ(ppm)=7.29 (m, 6H H11), 7.04 (m, 6H, H12), 3.79 (ABq, δA=3.80, δB=3.78, JAB=14 Hz, 6H, H5), 3.46 (X 
from ABX subsystem, JAX=6.3, JBX=6.6 Hz, 3H, H4), 3.11 (A subsystem from ABX, JAX=6.3, JAB=3.7 Hz, 3H, H9), 3.02 (B subsystem, 
from ABX JBX=6.6, JAB=3.7 Hz, 3H, H9), 2.86 (m, 3H, H2), 2.75 (m, 3H, H2), 2.43 (m, 3H, H1), 2.33 (m, 3H, H1), 2.29 (s, 9H, H8). 
 
19F NMR (376 MHz, CD3OD): δ(ppm)= -118.64 (m). 
 
13C NMR (101 MHz, CD3OD): δ(ppm)=174.5 (C3), 163.0 and 160,6 (C10, C13), 134.6 (C8),133.5 (C6), 130.9 (C11), 114.6 (C12), 62.4 
(C4), 56.6 (C1),45.5 (C5), 40.5 (C2), 37.1 (C9), 15.2 (C8).  
 
HRMS (ESI-TOF) m/z [1c+ H]+   Calc.: 798.4313, found: 798.4435 
 
 











Figure S17. 1H-NMR (400 MHz, methanol-d3), COSY, HSQC, HMBC and 19F-NMR spectra of 1c. 
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Synthesis of 1d  
 
 
Scheme S3. Full synthetic scheme of 1d 
2d tris((9H-fluoren-9-yl)methyl) ((2S,2'S,2''S)-((nitrilotris(ethane-2,1-diyl))tris(azanediyl))tris (3-(4-(tert-butoxy)phenyl)-1-
oxopropane-1,2-diyl))tricarbamate 
 
Figure S19. Structure of 2d 
Fmoc-L-Tyr(tBu)-OH (767 mg, 1.67 mmol) was dissolved in dry DMF (10 mL). N,N′-Dicyclohexylcarbodiimide hydrochloride (DCC·HCl 
O.39 mg, 2.02 mmol) and 1-hydroxybenzotriazole hydrate (HOBt, 273 mg, 2.02 mmol), dissolved in DMF (5 mL) were added over the 
solution. The solution was stirred at room temperature for 16 hours, when no more conversion of the starting material was observed by 
TLC. The mixture was then diluted with water and extracted with DCM (3 X 10 mL). Combined organic fractions were washed with 
aqueous LiCl (5% w/w), dried over MgSO4 and concentrated to dryness. The residue was purified by flash chromatography using 
DCM:MeOH 97:3 to give 614 mg of 2a (0.417 mmol, 81% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.65 (dd, J=12.0, 7.5 Hz, 6H), 7.38 (t, J = 7.4 Hz, 6H), 7.32 (t, J=7.4 Hz, 6H), 7.18 (q, J=8.0 Hz, 
6H), 7.08 (d, J=8.1 Hz, 6H), 6.78 (d, J=8.3 Hz, 6H), 6.02 (d, J=8.7 Hz, 3H), 4.65(m, 3H), 4.24 (m, 3H), 4.015 (m, 9H), 3.48 (m, 3H), 
3.20 (m, 3H), 3.01 (m, 3H), 2.87 (m, 3H), 2.77 (m, 3H), 2.36 (m, 6H), 1.94 (m, 3H), 1.70 (m, 6H), 1.69 (m, 12H), 1.36 (m, 6H), 1.23 (s, 
27H), 1.10 (m, 12H). 
 
13C NMR (101 MHz, CD3Cl): δ(ppm)=172.6, 156.7, 154.2, 143.8, 141.2,131.8, 129.9, 127.8, 127.2, 125.3, 124.213, 120.0, 78.3, 67.5, 
56.3, 54.5, 46.9, 38.8, 28.9. 
 
HRMS (ESI-TOF) m/z [2d+ H]+ Calc.: 1471.9190, found: 1471.7548. 
 






Figure S20.1H-NMR (400 MHz, CD3Cl) and 13C-NMR (101 MHz, CD3Cl) spectra of 2d 
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3d (2S,2'S,2''S)-N,N',N''-(nitrilotris(ethane-2,1-diyl))tris(2-amino-3-(4-(tert-butoxy)phenyl) propanamide) 
 
Figure S21. Structure of 3d 
2a (500 mg, 0.340 mmol) was dissolved in DCM/diethylamine (1 mL, 1:1). The solution was stirred at room temperature for 4 hours 
when the complete conversion of 2a was observed by TLC. After that, the solvent was evaporated and the solid was washed several 
times with hexane giving a 2b as a white solid (250 mg, 0.310 mmol, 91% yield)  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.63 (t, J=5.6 Hz, 3H), 7.12 (m, 6H), 6.90 (m, 6H), 3.54 (X subsystem from ABX, JAX=9.3, JBX=4.0 
Hz, 3H), 3.22 (m, 6H), 3.17 (B subsystem from ABX, JBX=4.0, JAB=3.7 Hz, 3H), 2.75–2.49 (A subsystem from ABX, JAX=9.3, JAB=3.7 
Hz, 3H overlapped with m, 6H), 1.32 (s, 27H). 
 
13C NMR (101 MHz, CD3Cl): δ(ppm)=173.8, 154.3, 132.2, 129.9, 124.4, 78.5, 56.5, 54.3, 49.2, 40.3, 29.0. 
 












































































































































































Figure S22. 1H-NMR (400 MHz, CD3Cl) and 13C-NMR (101 MHz, CD3Cl) spectra of 3d 
 
























Figure S24. Structure of 4d 
2c (230 mg, 0.286 mmol) was dissolved in ACN (50 mL). Tetrabuthylamonium chloride  (40 mg, 0.143 mmol), 1,3,5-tris(bromomethyl)-
2,4,6-trimethylbenzene (116 mg,  0.286mmol) and potassium carbonate (790 mg, 5.72 mmol) were added to the solution. The reaction 
mixture was refluxed for 16 hours under nitrogen atmosphere. After cooling down to room temperature, the solution was filtered, solvent 
was evaporated and the resulting crude was purified by flash column chromatography DCM:MeOH 97:3 as eluent to give 3c (90mg, 
93.7 mmol, 33% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=7.21 (d, J=8.5 Hz, 6H), 6.97 (d, J=8.4 Hz, 6H), 3.68 (ABq, δA=3.72, δB=3.65, JAB=13.6 Hz, 6H), 
3.43 (X subsystem from ABX, JAX=4.4, JBX=8.0 Hz, 3H), 3.28 (A subsystem from ABX, JAX=4.4, JAB=3.9 Hz, 3H), 2.94 (B subsystem 
from ABX overlapped with 3H, 6H), 2.65 (m, 6H), 2.38 (m, 3H), 2.26 (s, 9H), 1.34 (s, 27H). 
 
13C NMR (101 MHz, CDCl3): δ(ppm)=174.3, 154.4, 135.2, 132.7, 130.0, 124.6, 78.6, 63.7, 57.9, 46.6, 41.3, 37.9, 29.9, 29.0, 16.2. 
 
HRMS (ESI-TOF) m/z [4d + H]+ Calc.: 960.6321, found:  960.7116 
 
  




Figure S25. 1H-NMR (400 MHz, CD3Cl) and 13C-NMR (101 MHz, CD3Cl) spectra of 4d 
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Figure S27. Structure of 1d 
4d (90 mg, 93.7 mmol) was dissolved in DCM (1.5 ml). Triethylsilylsilane (0.15 mL, 1.1 mmol) and trifluoroacetic acid (1 mL) were 
added. The solution was stirred at room temperature during 3 hours and then solvents were evaporated under an air current affording 
a yellow oil. The residue was washed several times with diethyl ether and purified through reverse phase flash chromatography affording 
1d·4TFA as a white solid (108 mg, 86 mmol, 91 % yield).TFA  4d·4FTA was dissolved in methanol and amberlite IRA-95 resin was 
added while stirring until neutral to basic pH was reached. Finally, amberlite was filtered off and the solvent was evaporated to obtain 
1d (43 mg, 34 mmol, 77 % overall yield).  
 
1H NMR (400 MHz, CD3OD): δ(ppm)=7.09 (d, J= 8.2 Hz, 2H, H11), 6.72 (d, J= 8.1 Hz, 2H, H12), 3.78 (ABq, δA=3.82, δB=3.74, JAB=14 
Hz, 6H, H5), 3.40 (X subsystem from ABX, JAX=6.2, JBX=6.6 Hz, 3H, H4), 3.02 (A subsystem from ABX, JAX=6.2, JAB=3.7 Hz, 3H, H9) 
2.93 (B subsystem from ABX, JBX=6.6 JAB=3.7 Hz, 3H, H9), 2.0 (m, 6H, H2), 2.37 (m, 6H, H1), 2.27 (s, 9H, H8). 
 
13C NMR (100 MHz, CD3OD): δ(ppm)=174.7 (C3), 155.2 (C13), 135.9 (C7), 130.2 (C11), 128.2 (C6), 114.9 (C12), 62.5 (C4), 56.7 (C1), 
45.6 (C5), 40.7 (C2), 37.1 (C9), 15.3 (C8).   
 
HRMS (ESI-TOF) m/z [1d + H]+ Calc.: 792.443, found:  792.4522 
 
 









Figure S28. 1H-NMR (400 MHz, CD3OD), COSY, HSQC and HMBC spectra of 1c. 
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Synthesis of 1e 
 




Figure S30. Structure of 2E 
Boc-Trp-OH (300 mg, 0.99 mmol) was dissolved in dry DCM (5 mL) and DMF (0.4 mL).  (2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU O.375 mg, 0.989 mmol) N,N-diisopropylethylamine (DIPEA, 0.09 mL, 0.99 mmol) and 
tris(2-aminoethyl)amine (0.041 mL, 0.30 mmol) were added over the solution. The solution was stirred at room temperature for 16 
hours, after no more conversion of the starting material was observed by TLC. The mixture was diluted with more DCM and washed 
with water (3 X 10 mL). Combined organic fractions were washed with aqueous LiCl (5% w/w), dried over MgSO4 and concentrated to 
dryness. The residue was purified by flash chromatography using DCM:MeOH 95:5 to give 0.276 mg of 2e (0.275 mmol, 92% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=8.78 (s, 3H), 7.54 (d, J=7.9 Hz, 3H), 7.27 (d, J=8.1 Hz, 3H), 7.10 (t, J=7.5 Hz, 3H), 7.01 (t, J=7.5 
Hz, 6H), 6.97 (s, 3H), 6.41 (s, 3H), 5.54 (s, 3H), 4.39 (X subsystem from ABX JAX=8, JBX=6 Hz, 3H), 3.30–3.03 (m, A and B subsystems 
from ABX, JAX=8.0, JBX=5.7, JAB=4.4 Hz, 6H), 2.74 (m, 6H), 2.43 (m, 6H), 1.41 (s, 27H) . 
 
13C NMR (100 MHz, CD3Cl): δ(ppm)=172.5, 156.0, 136.2, 127.7, 123,7, 121.9, 119.4, 118.9, 111.4, 80.3, 55.9, 53.5, 53.0, 28.9, 28.4. 
 
HRMS (ESI-TOF) m/z [2e + H]+ Calc: 1005.5310, found: 1005.6048 
 









































































































































































































Figure S33. Structure of 3e 
2e (250 mg, 0.249 mmol) was dissolved in DCM (1.5 ml). Triethylsilylsilane (0.44 mL, 3.73 mmol) and trifluoroacetic acid (1 mL) were 
added. The solution was stirred at room temperature during 3 hours and then solvents were evaporated under an air current affording 
a yellow oil. It was washed several times with diethyl ether and dried affording 3·4TFA as a white solid (253 mg, 0.299 mmol, 88% 
yield).  
 
1H NMR (400 MHz, CD3OD): δ(ppm)=7.59 (d, J=7.8 Hz, 3H), 7.39 (d, J=8.1 Hz, 3H), 7.21 (s, 3H), 7.14 (t, J=7.5 Hz, 3H), 7.06 (t, J=7.4, 
3H), 4.10 (X subsystem from ABX, JAX=7.4, JBX=7.4 Hz, 3H), 3.41–3.33 (A and B subsystems from ABX, JAX=7.4, JBX=7.4 JAB=4.5 Hz 
overlapped with 6 additional H, 12H), 3.35 (m, 6H), 2.73 (m, 6H). 
 
13C NMR (101 MHz, CD3OD): δ(ppm)=199.3, 166.3, 156.5, 153.8, 151.1, 148.5, 147.3, 140.9, 136.2, 83.4, 81.5, 63.9, 56. 
 
HRMS (ESI-TOF) m/z [3e + H]+ Calc.: 705.3911, found:  705.4070 
 
  




Figure S34. 1H-NMR (400 MHz CD3OD) and 13C-NMR (101 MHz, CD3Cl) spectra of 3e 
 


























Figure S36. Structure of 1e 
3e (150 mg, 0.213 mmol) was dissolved in dry acetonitrile (40mL). Bu4Cl (29 mg, 0.106 mmol) and K2CO3 (588 mg, 4.25 mmol) were 
then added. 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (93.8 mg, 0.212 mmol) was dissolved in acetonitrile (10 mL) and the 
solution was added to the 3e solution. The reaction mixture refluxed for 16 hours. Solvent was evaporated and the resulting crude was 
purified by flash chromatography using DCM:MeOH 95:5 as eluent to give 1e as a white solid (64 mg, 57.7 mmol, 33% yield).  
 
1H NMR (400 MHz, CD3Cl): δ(ppm)=8.22 (s, 3H, H12), 7.66 (d, J=7.8 Hz, 3H, H17), 7.33 (d, J=8.0 Hz, 3H, H14), 7.26 (s, 3H, H11), 
7.10 (m, 9H, H15, H16), 6.18 (s, 3H, NHamide), 3.99 (ABq, δA=4.02, δB=3.94, JAB = 14 Hz, 6H, H5), 3.40 (m, 3H, H4), 3.21 (m, 6H, H9), 
2.46 (m, 3H, H2), 2.41 (s, 9H, H8), 2.06 (m, 6H, H2 and NHamine), 1.63 (m, 6H, H1). 
 
13C NMR (101 MHz, CD3OD): δ(ppm)=176.0 (C3), 140.0 (C7), 136.6 (C10), 135.5 (C6), 127.9 (C7), 123.8 (C15/16), 122.0 (C15/16), 
119.3 (C11), 118.7 (C17), 111.7 (C14), 110.2 (C13), 61.8 (C4), 56.3 (C1), 45.9 (C5), 40.2 (C2), 27.8 (C9), 16.3 (C8). 
 
HRMS (ESI-TOF) m/z [1e + H]+ Calc.: 861.485, found: 861.5199  
 
 










Figure S36. 1H-NMR (400 MHz CDCl3) 13C-NMR (101 MHz, CD3Cl/CD3OD(6:4)), HSQC and HMBC spectra of 1e 
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X-RAY crystal analysis  
Crystals were obtained by low evaporation of a methanolic solution of the corresponding compounds with an excess of concentrated 
aqueous HCl.  
 
Crystal structure determinations 
Data for all structures were collected on a STOE IPDS II two-circle diffractometer with a Genix Microfocus tube with mirror optics using 
MoKα radiation (λ = 0.71073 Å). The data were scaled using the frame scaling procedure in the X-AREA program system10. The 
structures were solved by direct methods using the program SHELXS 11 and refined against F2 with full-matrix least-squares techniques 
using the program SHELXL12 
 
In 1b, the methylene groups bonded to N1A are disordered over two sites with a site occupation factor of 0.576(11) for the major 
occupied sites. The absolute structure could be determined, Flack-x-parameter 0.05(4).  
 
In 1d, the methylene groups bonded to N1B, N1C, N1D, N1B, N1B, and the water O atom O56 are disordered over two sites with a 
site occupation factor of 0.627(16), 0.652(15), 0.652(16), 0.516(15), 0.689(16), 0.52(4), respectively, for the major occupied sites.  
The displacement parameters of the atoms C17Z, C37Z and C57Z were restrained to an isotropic behavior. 
The H atoms of the solvent water molecules could not be reliably located and were therefore omitted from the refinement. The absolute 
structure could be determined, Flack-x-parameter -0.01(3).  
 
                                                 
 
10 Stoe & Cie, X-AREA. Diffractometer control program system. Stoe & Cie, Darmstadt, Germany, 2002. 
11 a) G. M. Sheldrick, Acta Crystallogr. Sect. A, 2008, 64, 112−122; b) A. L. Spek, Acta Crystallogr. Sect. D, 2009, 65, 148−155. 
 
 




Figure S38 Perspective view of 1b with the atoms labels. Displacement parameters are drawn at the 50% probability level. Additional chloride counterions, solvent 
molecules and non-polar hydrogen atoms have been omitted for clarity. 





Figure S39 Perspective view of 1d with the most important atoms labels. Displacement parameters are drawn at the 30% probability level. Additional chloride 
counterions, solvent molecules and non-polar hydrogen atoms have been omitted for clarity. 
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  Table S1.  Crystal data and structure refinement for 1b. 
Identification code  n28 
Empirical formula  C48 H82 Cl4 N7 O13.50 
Formula weight  1115.00 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 11.8632(5) Å = 90°. 
 b = 33.6823(12) Å = 92.829(3)°. 





Density (calculated) 1.338 Mg/m
3
 




Crystal size 0.290 x 0.290 x 0.270 mm
3
 
Theta range for data collection 1.903 to 25.404°. 
Index ranges -14<=h<=14, -34<=k<=40, -16<=l<=16 
Reflections collected 28973 
Independent reflections 16705 [R(int) = 0.0450] 
Completeness to theta = 25.000° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.818 
Refinement method Full-matrix least-squares on F
2
 




Final R indices [I>2sigma(I)] R1 = 0.0602, wR2 = 0.1630 
R indices (all data) R1 = 0.0667, wR2 = 0.1688 
Absolute structure parameter 0.05(4) 
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Table S2.  Crystal data and structure refinement for 1d. 
Identification code  n29 
Empirical formula  C45 H61 Cl4 N7 O13 
Formula weight  1049.80 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 22.4388(4) Å = 90°. 
 b = 38.1669(11) Å = 100.331(2)°. 





Density (calculated) 1.330 Mg/m
3
 




Crystal size 0.260 x 0.180 x 0.110 mm
3
 
Theta range for data collection 1.663 to 25.176°. 
Index ranges -26<=h<=26, -45<=k<=41, -29<=l<=29 
Reflections collected 171230 
Independent reflections 70020 [R(int) = 0.0581] 
Completeness to theta = 25.000° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.599 
Refinement method Full-matrix least-squares on F
2
 




Final R indices [I>2sigma(I)] R1 = 0.0744, wR2 = 0.1720 
R indices (all data) R1 = 0.1294, wR2 = 0.2007 
Absolute structure parameter -0.01(3) 
Largest diff. peak and hole 1.548 and -0.595 e.Å
-3
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Titration with Tetrabuthylamonium chloride (TBACl): Binding constants  
 
The titrations were performed with the cage receptor as the fully protonated molecules, using trifluoroacetic acid (TFA). The 
corresponding tetra-TFA salts were prepared by dissolving each compound in methanol and adding an excess of trifluoroacetic acid, 
followed by the solvent evaporation and drying in vacuum. 
Stock solutions of the cage were prepared by weighting the corresponding amount of the receptor and reaching a final concentration 
between 1 and 2 mM. The solvent used was 95:5 CD3CN:H2O, since this mixture generally allowed a good solubility during the titration 
experiment and rendered reasonably sharp and well-defined 1H NMR spectra. Besides, under these conditions, the amide proton is 
detectable during the titration experiments. Additionally, a stock solution of the titrant containing 0.1 M TBACl was prepared by 
dissolving the salt in the stock solution of the cage. Thus, for each experiment, the solution of the titrant will be 0.1 M in TBACl and 
0.001-0.002 M in the receptor therefore maintaining the concentration of the cage constant during the titration experiment. The stock 
solution of the cage was introduced in a NMR tube and the 1H NMR spectrum (500 MHz, 303 K) was acquired, then small volumes of 
the stock solution of the titrant were added and the 1H NMR spectrum recorded after each addition. 
Different signals changed upon addition of chloride anion, and their variations were fitted using HypNMR 2008 version 4.0.71 software13. 
We tried different binding modes starting from the simplest 1:1 cage:chloride stoichiometry of the supramolecular complex, for which 
the fitting was unsatisfactory in all the cases. The simplest binding mode that led to a satisfactory fitting of all the proton signals 
corresponded to the formation of both 1:1 and 1:2 cage:chloride complexes. Because species with varied stoichiometry are formed in 
solution, for a suitable comparison of the systems, we calculated the BC500 parameter, using the BC50 calculator version 2.37.1 
program14.  
Following, we show the stacked plot of the NMR spectra for the titration experiments, the corresponding data set introduced 
(experimental) and obtained (fit) during the fitting process, the output values (both logβ and BC500) for the binding for every 
supramolecular complex, the plot of the experimental (symbols) and the fitted (lines) values of the chemical shifts, and the plot of the 
simulated species distribution obtained. 
Association constants for compound 1a had already been reported15. 
  
                                                 
 
13 a) C. Frassineti, S. Ghelli, P. Gans, A. Sabatini, M.S. Moruzzi and A. Vacca, Anal Biochem 1995, 231, 374–382; b) C. Frassineti, L. Alderighi, P. Gans, A. Sabatini, 
A.Vacca, S. Ghelli, Anal. Bioanal. Chem. 2003, 376, 1041–1052. 
14 a) C. Nativi, O. Francesconi, G. Gabrielli, A. Vacca, S. Roelens, Chem. Eur. J. 2011, 17, 4814–4820; b) A. Vacca, C. Venturi, S. Roelens Chem. Eur. J. 2009, 15, 
2635–2644. S. Roelens, A. Vacca, O. Francesconi, C. Venturi, Chem. Eur. J. 2009, 15, 8296–8302.  
15 I. Marti; J. Rubio, M. Bolte, M. I. Burguete, C. Vicent, I. Alfonso, S. V.  Luis, Chem. Eur. J. 2014, 20, 7458–7464. 
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Titration of 1b 
 
 
Figure S40. 1b Stacked 1H NMR spectra for the titration of 1b 
Table S3. Data set of 1b titration:  
[Cl] Cl eq. HAr2 HAr2 fit HB HB fit HB' HB' fit HE HE fit 
0.0000 0.0000 7.365 7.365 4.313 4.313 4.039 4.039 2.27 2.27 
0.0005 0.1815 7.603 7.5911 4.396 4.3828 4.086 4.0847 2.318 2.3167 
0.0011 0.3623 7.789 7.7828 4.447 4.4403 4.12 4.1199 2.356 2.3552 
0.0016 0.5425 7.926 7.9256 4.482 4.4808 4.137 4.1409 2.38 2.3823 
0.0022 0.7220 8.025 8.0236 4.505 4.5059 4.146 4.1495 2.397 2.399 
0.0027 0.9009 8.092 8.0919 4.519 4.5213 4.148 4.1507 2.408 2.4091 
0.0032 1.0791 8.133 8.1427 4.528 4.5313 4.148 4.1485 2.415 2.4157 
0.0038 1.2567 8.175 8.183 4.535 4.5383 4.146 4.1447 2.42 2.4202 
0.0043 1.4337 8.206 8.2162 4.539 4.5435 4.144 4.1404 2.423 2.4236 
0.0048 1.6100 8.25 8.2444 4.547 4.5476 4.139 4.1359 2.429 2.4262 
0.0059 1.9608 8.289 8.2904 4.553 4.5536 4.132 4.1273 2.432 2.43 
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0.0069 2.3091 8.323 8.3267 4.557 4.558 4.125 4.1195 2.435 2.4327 
0.0080 2.6549 8.372 8.3562 4.564 4.5613 4.111 4.1127 2.437 2.4348 
0.0105 3.5088 8.43 8.4108 4.571 4.5669 4.092 4.0991 2.438 2.4383 
0.0155 5.1724 8.458 8.4756 4.573 4.5731 4.081 4.0818 2.438 2.442 
 
Results of the HypNMR fitting:  
Logß 1= 3.69 ± 0.1 (1:1) 
Log ß 2= 5.89 (1:2) excessive relative error on beta= 37% 
BC50: 198 ±44µM 
 
Figure S41. Plot of the experimental (symbols) and fitting (lines) data in 1b titration 
 
Figure S42. Species distribution as a function of the chloride concentration in 1b titration.  
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Titration of 1c 
 
 
Figure S43. 1c Stacked 1H NMR spectra for the titration of 1c 
Table S4. Data set of 1c titration:  
Cl conc  [Cl] Cl eq. NH NH fit HB  HB fit HB' HB' fit HE HE fit 
0.000 0.000 0.000 7.528 7.528 4.318 4.318 4.072 4.072 2.294 2.294 
0.479 0.000 0.244 7.700 7.700 4.399 4.398 4.125 4.124 2.341 2.341 
0.956 0.001 0.488 7.850 7.859 4.473 4.472 4.174 4.172 2.384 2.383 
1.431 0.001 0.730 8.000 7.997 4.535 4.534 4.21 4.211 2.418 2.419 
1.905 0.002 0.972 8.108 8.106 4.582 4.582 4.237 4.238 2.446 2.447 
2.376 0.002 1.212 8.184 8.183 4.612 4.613 4.25 4.252 2.463 2.464 
3.080 0.003 1.571 8.253 8.253 4.636 4.637 4.257 4.257 2.477 2.477 
3.780 0.004 1.928 8.297 8.297 4.648 4.648 4.254 4.254 2.483 2.483 
5.166 0.005 2.636 8.348 8.349 4.657 4.657 4.241 4.240 2.488 2.486 
7.442 0.007 3.797 8.397 8.399 4.660 4.660 4.219 4.216 2.487 2.486 
10.115 0.010 5.161 8.439 8.434 4.659 4.659 4.192 4.195 2.483 2.483 
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14.436 0.014 7.365 8.467 8.470 4.658 4.658 4.171 4.171 2.479 2.480 
 
Results of the HypNMR fitting:  
Logß 1= 3.82 ± 0.028 (1:1) 
Log ß= 2: 5.99 ± 0.058 (1:2) 
BC50: 148 ± 10 µM 
 
Figure S44. Plot of the experimental (symbols) and fitting (lines) data of 1c titration 
 
 
Figure S45. Species distribution as a function of the chloride concentration of 1c titration.  
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Titration of 1d 
 
 
Figure S46. 1d Stacked 1H NMR spectra for the titration of 1d 
Tyrosine cage 1d starts to precipitate when we add more than one equivalent of TBACl, so association constants in this case are harder 
to determine. However, it was observed that first and second association constants are within the same order of magnitude, data that 
we obtain if we fix one value and optimize by fitting the other one. Nuclei used for the adjustment were ArH1. HB/B’ and HE.  
Table S5. Data set of 1d titration:  
[Cl ] Cl eq. HAr1  HAr1 fit HB HB fit HB' HB'fit HE HE fit 
0.0000 0.0000 7.0630 7.0630 4.3050 4.3050 4.0230 4.0230 2.2520 2.2522 
0.0005 0.2766 7.0760 7.0755 4.3490 4.3490 4.0540 4.0544 2.2830 2.2834 
0.0010 0.5521 7.0860 7.0863 4.3780 4.3783 4.0750 4.0744 2.3060 2.3057 
0.0015 0.8266 7.0960 7.0961 4.4000 4.3990 4.0880 4.0880 2.3230 2.3227 
0.0020 1.0999 7.1050 7.1050 4.4120 4.4132 4.0960 4.0965 2.3350 2.3356 
0.0025 1.3721 7.1130 7.1129 4.4220 4.4215 4.1010 4.1007 2.3450 2.3448 
 
Results of the HypNMR fitting:  
Logß 1= 3.74±0.04 (1:1) 
Log ß 2= 7.45±0.5 (1:2) 
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BC50: 115 ±34 µM 
 
Figure S47. Plot of the experimental (symbols) and fitting (lines) data of 1d titration 
 
Species distribution as a function of the chloride concentration. In this case the specie distribution is not accurate due to precipitation 
events of the 1:2 complex that is displacing the equilibrium towards the complexation of the cage.  
 
Figura S48. Species distribution as a function of the chloride concentration in 1d titration 
 
  




















































Titration of 1e 
 
 
Figure S.49. 4e Stacked 1H NMR spectra for the titration of 1e 
Table S6. Data set of 1e titration 
[Cl] Cl eq NHa NHa fit NHb NHb fit HB HB fit HB’ HB’fit HA HA fit 
0.00000 0.00 9.67 9.67 7.34 7.34 4.31 4.31 4.07 4.07 3.79 3.79 
0.00028 0.33 9.69 9.69  7.52 4.35 4.35 4.10 4.10 3.83 3.83 
0.00056 0.67 9.70 9.70  7.67 4.39 4.38 4.13 4.12 3.86 3.85 
0.00084 1.00 9.72 9.72 7.79 7.79 4.41 4.41 4.14 4.14 3.88 3.88 
0.00112 1.33 9.73 9.73 7.88 7.88 4.43 4.43 4.16 4.16 3.89 3.89 
0.00140 1.66 9.74 9.74 7.96 7.95 4.45 4.45 4.17 4.17 3.91 3.91 
0.00195 2.32 9.76 9.76 8.04 8.05 4.47 4.47 4.18 4.18 3.92 3.92 
0.00250 2.97 9.77 9.77 8.11 8.11 4.48 4.48 4.18 4.19 3.93 3.93 
0.00304 3.62 9.79 9.78 8.15 8.15 4.49 4.49 4.19 4.19 3.94 3.94 
0.00358 4.26 9.80 9.80 8.18 8.18 4.49 4.49 4.19 4.19 3.95 3.95 
0.00465 5.53 9.81 9.81 8.22 8.22 4.50 4.50 4.19 4.19 3.95 3.95 
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0.00596 7.10 9.83 9.83 8.25 8.25 4.51 4.51 4.19 4.19 3.96 3.96 
0.00852 10.2 9.85 9.85 8.29 8.29 4.52 4.52 4.20 4.19 3.96 3.96 
 
Results of the HypNMR fitting:  
Logß 1= 3.40 ± 0.03 (1:1) 
Log ß 2= 5.53 ± 0.12 (1:2) 
BC50: 380 ± 24 µM 
 
 
Figure S.50.Plot of the experimental (symbols) and fitting (lines) data in 1e titration 
 
Figure S51. Species distribution as a function of the chloride concentration in 1e titration. 
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LOG P calculation and Retention time determination  
 
LogP values for compounds were calculated using VCCLab software. This software allows the calculation of LogP using different 
methods such as ALOGPS, AC LogP, ALOGP, MLOGP, MiLOGP, XLOPGP2 or XLOGP3, and we used consensus LogP as the 
average of these values. Neutral (for logP1) and tetraprotonated (for LogP2) forms of the pseudopeptidic tripodal small cages were 
considered. The results are summarized in Table S7. Reverse phase HPLC (equipment: Agilent technologies 1100 series, column: X-
terra MS C18 4.6*150 mm (5 μM)) was also used for measuring the relative lipophilicity of these compounds, since the retention time 
of each molecule on the reverse phase column is related to its lipophilicity. 
All the products were dissolved in MeOH at concentration of 1 mM and eluted using a linear gradient of 20 % to 100 % of acetonitrile 
in water (using 0.1% of trifluoroacetic acid) in 20 minutes. 
 
 
Figure S52. General structures of the neutral and tetraprotonated cage. 
 
Figure S53. HPLC chromatogram of compound 1a 
 
Figure S54. HPLC chromatogram of compound 1b 
 
 


































Figure S55. HPLC chromatogram of compound 1c 
 
Figure S56. chromatogram of compound 1d 
 
Figure S57. HPLC chromatogram of compound 1e 
Table S7.: calculated Log P values and retention times (minutes). Log P1 correspond to the non-protonated cage and Log P2 corresponds to the tetraprotonated 
form of the cage. 
Cage LogP1 LogP2 Average LogP1 and LogP2 Retention time (min) 
1a 3.56 0.26 1.91 8.017 
1b 3.63 0.1 1.865 8.431 
1c 4.31 0.77 2.54 9.435 
1d 2.81 -0.69 1.06 5.067 
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Vesicles transport assays  
 
Preparation of vesicles  
Vesicles composed of POPC (1-palmitoyl-2- oleoyl-sn-glycero-3-phosphocholine) or POPC and cholesterol were used. POPC and 
cholesterol stock solutions were prepared in chloroform and were kept in the freezer. In a standard preparation 2 mL of POPC stock 
solution (20 mg/mL = 26.32 mM) were added to a 5 mL round bottom flask. The solvent was evaporated using a rotary evaporator (20 
°C) and dried overnight under high vacuum. On the next morning, the obtained lipid film was rehydrated with 1 mL of the required 
internal solution corresponding to each assay, followed by careful vortexing. The obtained lipid suspension, composed of multilamellar 
vesicles with different sizes, was subjected to seven freeze-and-thaw cycles. At this point, the lipid solution was made of unilamellar 
vesicles with different sizes. In order to standardize the size, the suspension was extruded through 200 nm polycarbonate nucleopore 
membrane using a LiposoFast Basic extruder (Avestin, Inc.) 29 times. Once the vesicles were prepared, the next step was to remove 
the non-encapsulated contents of the rehydrating solution. There are two different manners of carrying this out. One of them consists 
in placing the lipid suspension in a dialysis membrane and dialyse it against the external required solution (2 times x 500 mL). This 
method was used for ISE experiments. The other method consists in carrying out a Size Exclusion Chromatography (SEC) on a 
Sephadex G-50 column. This method was used for removing fluorescent dyes. Finally, the vesicles suspension was place in a 
volumetric flask, to obtain a stock liposome suspension of known lipid concentration  
 
Transport assays  
Potentiometric transport assays. Chloride selective electrode assays. 
This assay is focused on determining the chloride concentration using a Chloride Selective Electrode (Ion Selective Electrode, ISE)16 
POPC vesicles were prepared as previously described. All ISE assays were carried out using a total volume of 5000 μL. Unilamellar 
vesicles were suspended in the external solution to give a final lipid concentration of 0.5 mM POPC. At t = 60 s (unless other 
specification), a DMSO solution of the anion carrier was added to the sample. The volume of stock solution added was always smaller 
than 25 μL in order to avoid influence of the solvent. The chloride efflux from the vesicles was monitored over time, using the 
combination chloride selective electrode. At t = 300 s, a 20 μL pulse of Triton X-10% (v/v) (detergent) was added in order to lyse the 
vesicles and release all chloride anions. This total value of chloride anions was considered as 100 % and the rest of data points were 
normalized as a function of it. Data was expressed as percentage of Cl- efflux over time. The initial clhoride efflux rates shown in Table 
1 of the manuscript were calculated divinding the % of chloride effluxed (% Cl) at t = 60 s by the time (s). 
 
NO3-/Cl- exchange at pH 7.2 both in and out of the vesicles 
 Intravesicular solution: 489 mM NaCl, I.S. 500 mM, NaH2PO4 5 mM, pH 7.2. 
 Extravesicular solution: 489 mM NaNO3, I.S. 500 mM, NaH2PO4 5 mM, pH 7.2. 
 t = 0 s vesicles + buffer. 
 t = 60 s anion carrier addition in DMSO solution. 
 t = 300 s 20 μL Triton X (10% v/v). 
 Total time: until stable lecture after the detergent addition (30–60 s). 
 
Figure S58. Anion transport activity of 1a-e (50 µM =10 mol%) ISE experiment. 0.5 mM POPC. Vesicles loaded with 489 mM NaCl (phosphate buffer 5 mM, pH 
7.2) where suspended in NaNO3 489 mM (phosphate buffer 5 mM, pH 7.2). At t = 300 s a pulse of detergent was added in order to release all chloride anions.  
NO3-/Cl- exchange at pH 7.2 outside and pH 6.2 inside the vesicles 
 Intravesicular solution: 489 mM NaCl, I.S. 500 mM, NaH2PO4 5 mM, pH 6.2. 
                                                 
 
16 L. A. Jowett, P. A. Gale, Supramol. Chem. 2019, 31, 297-312. 
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 Extravesicular solution: 489 mM NaNO3, I.S. 500 mM, NaH2PO4 5 mM, pH 7.2. 
 t = 0 s vesicles + buffer. 
 t = 60 s anion carrier addition in DMSO solution. 
 t = 300 s 20 μL Triton X (10% v/v). 
 
Figure S59. Anion transport activity of 1a-e (50 µM =10 mol%) ISE experiment. 0.5 mM POPC. Vesicles loaded with 489 mM NaCl (phosphate buffer 5 mM, pH 
6.2) where suspended in NaNO3 489 mM (phosphate buffer 5 mM, pH 7.2). At t = 300 s a pulse of detergent was added in order to release all chloride anions.  
NO3-/Cl- exchange at pH 6.2 outside and 6.2 inside the vesicles 
 Intravesicular solution: 489 mM NaCl, I.S. 500 mM, NaH2PO4 5 mM, pH 6.2. 
 Extravesicular solution: 489 mM NaNO3, I.S. 500 mM, NaH2PO4 5 mM, pH 7.2. 
 t = 0 s vesicles + buffer. 
 t = 60 s anion carrier addition in DMSO solution. 
 t = 300 s 20 μL Triton X (10% v/v). 
 
Figure S60. Anion transport activity of 1a-e (50 µM =10 mol%) ISE experiment. 0.5 mM POPC. Vesicles loaded with 489 mM NaCl (phosphate buffer 5 mM, pH 
6.2) where suspended in NaNO3 489 mM (phosphate buffer 5 mM, pH 6.2). At t = 300 s a pulse of detergent was added in order to release all chloride anions.  
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Fluorescence based transport assays. 
 
These assays are based on fluorophores whose fluorescence varies as a function of changes in different variables such as 
concentration (carboxyfluorescein), pH (HPTS) or the presence of some ions (lucigenin is selectively quenched by chloride). POPC 
and POPC : cholesterol (7:3) vesicles were prepared as previously described. The non-encapsulated rehydrating solution was removed 
by SEC, using as mobile phase the external buffer. The intra- and extravesicular compositions are outlined below. The total volume in 
the cuvettes was 2500 μL. Unless other specification, the anion carrier was added at t = 60 s and fluorescence changes were monitored 
over time. 
 
Lucigenin based assays  
 Extravesicular solution: 102.2 mM NaCl, I.S. 150 mM, NaH2PO4 20 mM, pH 7.2. 
 t = 0 s vesicles + buffer. 
 t = 60 s anion carrier addition in MeOH solution. 
 Total time 360 s. 
 λexc = 372 nm; λem = 503 nm. 
Lucigenin is a bisacridinium salt whose fluorescence emission is quenched by halides. (Ksv, Cl - = 390 M1).17 Based on these properties, 
lucigenin could be employed to monitor the chloride transport inside vesicles at 503 nm after exciting at 372 nm. Data collected was 
represented as initial fluorescence divided by fluorescence vs time (f0/f).  
 
Figure S61. f0/f normalization of lucigenin fluorescence emission upon addition of cages 1a-e to POPC:Cholesterol (7:3) vesicles, 0.25 mM POPC. Vesicles 
contained NaNO3 (102.2 mM NaNO3, I.S. 150 mM, NaH2PO4 20 mM, pH 7.2; lucigenin 3 mM) were suspended in NaCl (102.2 mM NaCl, I.S. 150 mM, NaH2PO4 20 
mM, pH 7.2). At t = 60 s the anion carrier was added (10 mol% carrier to lipid; 0.025 mM). Blank (12.5 µL MeOH). Each trace represents the average of at least 
three different trials, done with at least two different batches of vesicles. 
5(6)-carboxyfluorescein based assays  
 POPC vesicles 0.05 mM  
 Intravesicular solution: 451 mM NaCl, I.S. 500 mM, NaH2PO4 20 mM, pH 7.2; carboxyfluorescein 50 mM. 
 Extravesicular solution: 150 mM Na2SO4, I.S. 500 mM, NaH2PO4 20 mM, pH 7.2 
 t = 0 s vesicles + buffer 
 t = 60 s anion carrier addition in DMSO solution 
 t = 360 s detergent. The fluorescence was recorded 2 more minutes 
 Total time = 480 s 
 λexc = 490 nm; λem = 520 nm 
Data processed:  
The following equation is applied to the obtained data.  






 It → fluorescence intensity at time t. 
                                                 
 
17 a) J. Biwersi, B. Tulk, A. S. Verkman, Anal. Biochem., 1994, 219, 139–143; b) C. Huber, K. Fähnrich, C. Krause and T, Werner, J. Photochem. Photobiol., 1999, 
128, 111–120. 
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 I0 → fluorescence intensity at time 0 s. 
 Imax → maximum fluorescence intensity observed after addition of detergent. 
 
Figure S62. Carboxyfluorescein leakage upon addition of 1a-e to POPC vesicles, 0.05 mM. Vesicles contained NaCl (451 mM, buffered with NaH2PO4 20 mM to 
pH 7.2, I.S. 500 mM and 50 mM CF) were suspended in Na2SO4 (150 mM, buffered with NaH2PO4 20 mM to pH 7.2, I.S. 500 mM). At t = 60 s addition of the anion 
carrier (10 mol% carrier to lipid). At t = 360 s addition of 20 µL of detergent. blank (12.5 µL DMSO). Each trace represents the average of at least three different 
trials, done with at least two different batches of vesicles 
HPTS based assays 
 
HPTS based assay with NaNO3:  
 POPC:cholesterol (7:3) vesicles 0.5 mM in POPC 
 Intravesicular solution: 126.2 mM NaNO3, I.S. 150 mM, NaH2PO4 10 mM, pH 6.5; HPTS 10 μM 
 Extravesicular solution: 126.2 mM NaNO3, I.S. 150 mM, NaH2PO4 10 mM, pH 7.5 
 t = 0 s vesicles + buffer 
 t = 60 s anion carrier addition in DMSO solution. 
 Total time 360 s 
 λexc = 403 nm and 460 nm; λem = 510 nm 
 
HPTS based assay with NaCl:  
 POPC:cholesterol (7:3) vesicles 0.5 mM in POPC 
 Intravesicular solution: 126.2 mM NaCl, I.S. 150 mM, NaH2PO4 10 mM, pH 6.5; HPTS 10 μM 
 Extravesicular solution: 126.2 mM NaCl, I.S. 150 mM, NaH2PO4 10 mM, pH 7.5 
 t = 0 s vesicles + buffer 
 t = 60 s anion carrier addition in DMSO solution. 
 Total time 360 s 
 λexc = 403 nm and 460 nm; λem = 510 nm 
 
The relationship between the fluorescence intensity at 510 nm when the sample is excited at both 460 and 403 nm allows to determine 
the internal pH at each time:  
𝐹𝑖 𝑒𝑚 510 𝑛𝑚 (𝜆𝑒𝑥 460 𝑛𝑚)
𝐹𝑖 𝑒𝑚 510 𝑛𝑚 (𝜆𝑒𝑥 403 𝑛𝑚)
 
 
A calibration curve for determining the actual pH value as function of the ratiometric emission of HPTS was carried out using 15 nM 
HPTS in the phosphate buffer solutions used in the measurements (with NaNO3 and with NaCl) and adding consecutive aliquots of 
NaOH 0.5 M to the solution to raise the pH from 5.5 to 9.5. After each addition the fluorescence rate was read. The representation of 
the emission ration (I406/I403) vs the pH was adjusted to a S-Logistic model18 .  
 
                                                 
 
18 N. Busschaert, P. A. Gale, C. J. E. Haynes, M. E. Light, S. J. Moore, C. C. Tong, J. T. Davis, W. Harrell, Chem. Commun, 2010, 46, 6252-6254. 





































Figure S63. HPTS calibration s-logistic1 model (126 mM NaCl,10 mM buffer phosphate). 
The conversion of fluorescence data into pH was done with the corresponding S-Logistic1 model obtained from the calibration curve 
at the experimental condition.  
 
Figure S64. Variation of pH upon addition of compounds 1a-e (10 mol%) to POPC:cholesterol (7:3) vesicles, 0.5 mM POPC. Vesicles contained NaCl (126.25 mM 
NaCl, 10 mM buffer phosphate pH 6.5, I.S. 150 mM and HPTS 10 µM) were suspended in NaCl (126.25 mM NaCl, 10 mM buffer phosphate and I.S. 150 mM). At t 
= 60 s addition of the anion carrier. (blank (12.5 µL DMSO)). Each trace represents the average of at least three different trials from at least two different batches 
of vesicles. 
  


























































Figure S65. Plot of the pH value upon addition of compounds 1a-e (10 mol%) to POPC:cholesterol (7:3) vesicles, 0.5 mM POPC. Vesicles contained NaCl (126.25 
mM NaCl, 10 mM buffer phosphate, I.S. 150 mM and HPTS 10 µM) were suspended in NaCl (126.25 mM NaCl, 10 mM buffer phosphate and I.S. 150 mM). At t = 
















 1a  1d
 1b  1e
 1c  blank 
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Figure S66. Representative fittings (ln(I/I0) versus g2, Eq.1) for diffusion coefficients measurements (sample 1.0 mM cage 1c in DMSO-d6/5 mM TBACl/10 mM 
TFA-d1) obtained using Dynamics Center software from Bruker  
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Table S8. Translational diffusion coefficient measured by NMR spectroscopy for 1c samples in DMSO-d6 or DPC-d38 micelles at different pH values and salt 
concentration. 
 
   D (10-11 m2·s-1) SD (10-11  m2·s-1) 
0.4 mM 1c DMSO-d6/5 mM TBACl/10 mM TFA-d1   
2,6-H Aromatic region 14.98 0.003095 
3,5-H Aromatic region 15.08 0.002951 
DMSO-d6 76.10 0.010090 
0.4 mM 1c DMSO-d6   
2,6-H Aromatic region 18.53 0.002400 
3,5-H Aromatic region 18.32 0.002372 
CH3 18.60 0.002403 
DMSO-d6 74.62 0.008677 
0.4 mM 1c:25 mM DPC (D2O, pH 2.6)   
2,6-H Aromatic region 8.824 0.000525 
3,5-H Aromatic region 8.856 0.000482 
CH3 8.936 0.000458 
DPC CH3 n.m. (broad) n.m. (broad) 
DPC CH2 11.113 0.013930 
0.4 mM 1c:25 mM DPC (D2O, 150 mM NaCl, pH 2.6)   
2,6-H Aromatic region 8.810 0.001428 
3,5-H Aromatic region 8.870 0.001054 
CH3 8.867 0.001075 
DPC CH3 n.m. (broad) n.m. (broad) 
DPC CH2 11.160 0.000333 
0.4 mM 1c:25 mM DPC (D2O, pH 7.1)   
2,6-H Aromatic region 8.844 0.000432 
3,5-H Aromatic region 8.914 0.000313 
CH3 8.917 0.000294 
DPC CH3 10.903 0.001280 
DPC CH2 12.590 0.001531 
0.4 mM 1c:25 mM DPC (D2O, 150 mM NaCl, pH 7.1)   
2,6-H Aromatic region 8.751 0.009715 
3,5-H Aromatic region 8.808 0.007750 
CH3 8.743 0.006564 
DPC CH3 10.680 0.003462 
DPC CH2 11.500 0.003900 






Figure S67. Part of the 2D 1H-1H NOESY spectrum (250 ms mixing time, pulse sequence noesygpphzs) of 1 mM 1c cage in DMSO-d6 with NOE’s assignments. 
The inset shows the 1H-1H COSY crosspeak between the cage amide and H-C proton. 
  







Figure S68. Part of the 2D 1H-1H EASY-ROESY spectrum (50 ms mixing time, pulse sequence roesyadjsphpr) of 1 mM 1c in DMSO-d6 with ROE’s assignments. 
 
  






Figure S69. 2D 1H-13C HSQC spectrum (pulse sequence hsqcedetgpsisp2.3) of 1 mM 1c in DMSO-d6. 
  






Figure S70. Part of the 2D 1H-1H COSY spectrum (pulse sequence cosygpmfqf) of 1 mM 1c cage in DMSO-d6. 
  




Figure S71. A comparison of the 1H spectra of 1 mM 1c non-protonated cage in DMSO-d6 (red spectrum) and protonated in presence of chloride (blue spectrum). 
 
 
Figure S72. A comparison of the aromatic region of 1H spectra of 1c in different solvent conditions (1 mM in DMSO-d6 and 0.4 mM in DPC/D2O). 
  







Figure S73. A comparison of the aliphatic region of 1H spectra of 0.4 mM 1c in DPC-d38/D2O micelles at pH 2.3-2.6 without (red spectrum) and with (blue spectrum) 
150 mM NaCl. 
  






Figure S74. Part of the 2D 1H-1H ROESY spectrum (75 ms mixing time, pulse sequence roesygpph19) of 0.4 mM 1c in DPC-d38/D2O micelles at acid pH with 150 
mM NaCl. Superscripts 1 and 2 indicate the presence of several species in slow exchange in the chemical shift timescale (possibly 1-free and 2-chloride bound). 
  






Figure S75. A comparison of the aliphatic region of 1H spectra of 0.4 mM 1c in DPC-d38/D2O micelles at pH 7.1 without (red spectrum) and with (blue spectrum) 
150 mM NaCl. 
 
  






Figure S76. Parts of the 2D 1H-1H COSY spectrum (pulse sequence cosygpprqf) of 0.4 mM 1c in DPC-d38/D2O micelles at pH 7.1 without salt. Superscripts 1 and 
2 indicate the presence of different species in slow exchange in the chemical shift timescale. 
  






Figure S77. Part of the 2D 1H-1H NOESY spectrum (250 ms mixing time, pulse sequence noesyfpgpphwg) of 0.4 mM 1c in DPC-d38/D2O micelles at pH 7.1 without 
salt. Superscripts 1 and 2 indicate the presence of several species in slow exchange in the chemical shift timescale. 
  






Figure S78. Part of the 2D 1H-1H ROESY spectrum (75 ms mixing time, pulse sequence roesygpph19) of 0.4 mM 1c in DPC-d38/D2O micelles at pH 7.1 without 
salt. Superscripts 1 and 2 indicate the presence of several species in slow exchange in the chemical shift timescale. 
  






Figure S79. Part of the 2D 1H-1H ROESY spectrum (75 ms mixing time, pulse sequence roesygpph19) of 0.4 mM 1c in DPC-d38/D2O micelles at pH 7.1 without 
salt (above) and with 150 mM NaCl (below). Superscripts 1 and 2 indicate the presence of several species in slow exchange in the chemical shift timescale. 
  




Figure S80. Methyl region of the 1H spectra of 0.4 mM 1c in DPC-d38/D2O micelles at acid/neutral pH and without/with salt. For comparison purposes, the small 
differences in DPC/cage resonances chemical shift due to presence of salt or different pH’s are corrected using the DMSO-d5 residual resonance as chemical shift 
reference at 2.674 ppm. 
 
Figure S81. Methyl region of the 1H-13C HSQC spectrum of 0.4 mM 1c in DPC-d38/D2O micelles at neutral pH without salt. 
For the sample of 1c in DPC-d38/D2O micelles at acid pH in the presence of 150 mM salt, we observed two groups of resonances for 
the methyl protons in slow exchange, CH31 and CH32, corresponding to free (minor) and chloride-bound cage (major), respectively (see 
figure S80). For 1c in DPC-d38/D2O micelles at neutral pH, we also observed two groups of resonances for the cage methyl protons 
with and without salt, CH31 and CH32. In this case, we propose that the minor species (2-superscript) corresponds to HCl-bound 1c, in 
much lower concentration at neutral pH. 
  





Figure S82. Comparison of the 2D 1H-1H ROESY spectra of 0.4 mM 1c in DPC-d38/D2O/150 mM NaCl micelles at neutral and acid pH. Exchange resonances for 
4FPhe ortho protons between the two observed species (free and chloride-bound) are indicated. 
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Cell cultures  
 
Human lung adenocarcinoma cells, A549 were maintained in Dulbecco’s modified eagle’s medium (DMEM; Gibco Thermo Fisher 
Scientific, USA) with carbonate buffer. Cells were kept in the logarithmic growth phase by routine passage every 2-3 days using 0.025% 
trypsin-EDTA treatment. 
pH 7.2 and 6.2 media were prepared replacing the carbonate by PIPES buffer (10 mM) and adjusting the pH with HCl or NaOH. pH 7.6 
media (with carbonate buffer) is the same used for cell growth. 
 
Cytotoxicity vs cancer cells  
 
The antiproliferative activity of compounds 1a-e was evaluated using the MTT assay method. Cells were seeded 24 hours prior to 
treatment in 96-well plate (100 µL of a suspension 2.5·105 cell/mL). The following day, culture media from the wells was replaced by 
100 µL of fresh media at each pH containing the desired concentration of the compound to be tested. All the compounds were previously 
dissolved in DMSO at a concentration of 20 mM. The final concentration of DMSO used in the corresponding wells did not exceeded 
1% (v/v). This concentration does not affect cell viability. Negative control cultures received the same concentration of solvent alone.  
Cells were incubated for 24h in the presence of compounds 1a-1e at 37°C in a humidified atmosphere with 5% CO2. At the end of 
incubation, culture media was removed and 100 µL of MTT solution (5mg/mL diluted with plain culture media 1:5) was added to each 
well and incubated for 4 hours. Afterwards, MTT solution was discarded. The purple formazan crystal formed at the bottom of the wells 
was dissolved with 100 µL of DMSO and stirred for 30 minutes at room temperature. The absorbance at 570 nm was read on a 
spectrophotometer plate reader. The proportion of surviving cells was calculated as Absorbance of treated sample/ Absorbance of 
control x 100. Dose-response curves were constructed to obtain IC50 values using Origin dose-response fitting function. All experimental 
data were derived from at least 3 independent experiments. 
Control cells were grown in the same conditions (same cell culture media, buffer and pH) as treated cells to ensure that the difference 
in viability is only associated to the corresponding cages and not the buffer or the pH of the medium.  
 
In order to ensure the suitability of PIPES buffer in the experimental conditions (10 mM, 24h incubation) pH of the media with PIPES 
at both pH 7.2 and 6.2 was measured before incubation, and after 24 hours incubation with A549 cancer cells in the presence of the 
cages. The corresponding pH changes in all the cases were lower than 0.12 pH units so we concluded that this buffer concentration 
was enough to maintain the extracellular pH constant during the experiment. 
 
The antiproliferative activity of compound 1c in DPBS with different concentrations of chloride in the buffer was carried out as follows: 
Cells were seeded 24 hours prior to treatment in 96-well plate (100 µL of a suspension 2.5·105 cell/mL). The following day, culture 
media from the wells was replaced by 100 µL of fresh DPBS with the desired concentration of chloride and previously adjusted to pH 
6.4 containing different concentrations of compound 1c (from the 20 mM stock solution in DMSO). Negative control cultures received 
the same concentration of solvent alone. The rest of the assay was carried out as described for the previous MTT assays. The DPBS 
solutions with different concentrations of chloride were prepared by replacing NaCl with sodium gluconate. pH was adjusted before 
each experiment to 6.4 by adding NaOH or HCl. 
 
Statistical analysis: GraphPad Prism v5.0 software (GraphPad Software Inc., La Jolla, USA) was used for statistical analysis. For all 
experiments, the obtained results of the triplicates were represented as means with standard deviation (SD). 
  




Figure S83. Cytotoxicity of compound 1c (70, 50 and 30 μM) towards A549 cells determined by the  MTT assay after 24h of incubation 
in DPBS containing different concentrations of chloride (14, 35, 70, 140 mM) at pH 6.4. The cell viabilities were calculated considering 
their respective negative controls. 
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